Board of Directors

Eduardo AlfonsoEduardo C. Alfonso, MD, Chairman of the Department of Ophthalmology of the University of Miami Miller School of Medicine and director of the Bascom Palmer Eye Institute's patient care facilities, Anne Bates Leach Eye Hospital in Miami, and outpatient facilities in Palm Beach Gardens, Plantation and Naples, Florida, is one of the most recognized ophthalmologists in the world. Holder of the Edward W. D. Norton Professor of Ophthalmology until 2009, when he was named to the Kathleen and Stanley Glaser Distinguished Chair in Ophthalmology, he is known for his clinical expertise in diseases and surgery of the cornea and ocular microbiology and laser vision correction. He has published numerous articles in refereed journals, chapters, and has been guest lecturer nationally and internationally. He is fellow of the American Academy of Ophthalmology where he has been awarded the distinguished honor award and senior honor award. He has been named as one of America's Top Doctors since 1992. Dr. Alfonso graduated summa cum laude from Yale University in 1976. He graduated from Yale Medical School in 1980. His ophthalmology residency was completed at the Bascom Palmer Eye Institute of the University of Miami School of Medicine. He completed fellowships in cornea and ocular pathology at the Massachusetts Eye and Ear Infirmary at Harvard Medical School.

Back to Board

Dr. Julia A. Haller, MD, is Ophthalmologist-in-Chief of the Wills Eye Institute, where she holds the William Tasman, M.D. Endowed Chair. She serves as Professor and Chair of the Department of Ophthalmology at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospitals. She was educated at the Bryn Mawr School in Baltimore, Princeton University, and Harvard Medical School. She was an ophthalmology resident, retina fellow, and the first female chief resident at the Wilmer Eye Institute at Johns Hopkins Hospital, and went on to hold both the Katharine Graham and Robert Bond Welch, M.D. Professorships there before assuming leadership at Wills.

Her honors include the Rolex Achievement Award (to a past participant in collegiate varsity lacrosse), the Crystal Apple Award of the American Society of Retina Specialists for teaching and mentorship, the Kreissig Award from EURETINA, the President's Award from Women in Ophthalmology, a Secretariat Award from the AAO, the Gertrude Pyron Award from the Retina Research Foundation and the ASRS, and a Lifetime Achievement Award from the AAO.

Dr. Haller has published over 250 papers in the peer reviewed literature as well as 22 book chapters. She is past president of the American Society of Retina Specialists, Vice-President and President Elect of the Retina Society, and a member of the Executive Committee of the Macula Society and the Board of Trustees of the Association of University Professors of Ophthalmology. She serves on the editorial boards of RETINA, Retinal Physician, Retina Times, Ocular Surgery News, Retina Today, Ophthalmology Times, EyeWorld, and Evidence-Based Eye Care.

Dr. Haller serves on the Board of the American Retina Foundation, the Board of the ARVO Foundation for Eye Research, and the Board of Trustees of Princeton University.

Back to Board

Stephen McLeodStephen D. McLeod, MD, is the Theresa M. and Wayne M. Caygill M.D. Endowed Chair and Professor and Chairman, Department of Ophthalmology at the University of California, San Francisco.

Dr. McLeod's subspecialties include refractive surgery, and cornea and external disease. In the field of refractive surgery, Dr. McLeod's work involves the diagnosis and surgical management of refractive error through techniques such as laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). In the field of cornea and external disease, Dr. McLeod diagnoses and treats of corneal, conjunctival and anterior segment disorders, corneal infection, inflammation and opacification, ocular surface tumors, trauma, adult cataract and intraocular lens complications, as well as infantile developmental corneal anomalies and pediatric cataract.

Dr. McLeod's research interests are broad, extending from refractive surgery to the diagnosis and management of eye infections both in the U.S. and in the developing world. His major areas of work include the development of implanted accommodating devices for the treatment of presbyopia, as well as the development of materials to improve the performance of artificial corneas. He is also conducting a series of studies designed to improve diagnostic tests for bacterial infections of the eye, a major blinding condition around the world.

Dr. McLeod is active in a number of national organizations. He serves as an examiner for the American Board of Ophthalmology; co-editor for the Archives of Ophthalmology OnLine; and as an editorial board member for the Archives of Ophthalmology, the scientific ophthalmology journal of the American Medical Association. He also serves on the ophthalmic devices advisory panel of the FDA.

Back to Board

Joan MillerJoan W. Miller, MD, is the Henry Willard Williams Professor of Ophthalmology & Chair, Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital. Dr. Joan Whitten Miller was born in Toronto, Ontario, Canada and is a graduate of Massachusetts Institute of Technology and Harvard Medical School. She completed her ophthalmology residency and a vitreo-retinal fellowship at Massachusetts Eye and Ear Infirmary. Dr. Miller is the first female physician promoted to the rank of Professor of Ophthalmology at Harvard Medical School, and the first woman to serve as chair of the Department of Ophthalmology. Additionally, Dr. Miller is the director of Mass. Eye and Ear's Angiogenesis Laboratory and a vitreo-retinal physician in the Retina Service at the Infirmary.

Dr. Miller's research interests focus on ocular neovascularization, particularly as it relates to age related macular degeneration (AMD) and diabetic retinopathy, including the molecular mechanisms of angiogenesis and neuroprotection, the development of effective therapies, and drug delivery. She and her colleagues at Mass. Eye and Ear pioneered the development of photodynamic therapy (PDT) using verteporphin (Visudyne®), the first pharmacologic therapy for AMD able to reduce and slow vision loss. The group also identified the importance of vascular endothelial growth factor (VEGF) in neovascular AMD, and helped develop the anti-VEGF therapies pegaptanib and ranibizumab—the latter able to improve vision in about one-third of patients with neovascular AMD. While these approaches have improved the outlook for patients with AMD, Dr. Miller and her colleagues continue investigations to elucidate the pathophysiology of vision loss and improve therapies for AMD.

An internationally recognized expert in the field of macular degeneration, Dr. Miller has published more than 130 peer-reviewed papers, 50 book chapters and review articles, is co-editor of the third edition of Albert and Jakobiec's Principles and Practice of Ophthalmology, and is a named inventor on nine U.S. patents and five Canadian patents. She has received numerous awards, including the Rosenthal Award and Donald J. Gass Medal of the Macula Society, the Retina Research Award from the Club Jules Gonin, the Alcon Research Institute Award, the ARVO/Pfizer Ophthalmic Translational Research Award, the Founder's Award from the American Society of Retinal Specialists, the Harvard Medical School 2010 Joseph B. Martin Dean's Leadership Award for the Advancement of Women Faculty, the Suzanne Veronneau-Troutman Award from Women in Ophthalmology, the Paul Henkind Memorial Award from the Macula Society, and the Senior Achievement Award from the American Academy of Ophthalmology. Dr. Miller will deliver the 2012 Edward Jackson Lecture for the American Academy of Ophthalmology.

Dr. Miller and her husband John live in Winchester, MA. John, a construction attorney, specializes in domestic and international engineering procurement and public-private partnerships in global infrastructure. Their son John, the eldest of three children, is currently an ophthalmology resident at Harvard Medical School. Their son Douglas is a 2010 graduate of Harvard College, where he was co-captain of his college basketball team; he now works in construction management for Schernecker Property Services. Daughter Mary graduated from Harvard College in 2011, and is working as a paralegal for the law firm Harkins Cunningham LLP in Philadelphia.

Back to Board

David WilsonNicholas J. Volpe, MD Recently appointed as the George and Edwina Tarry Professor and Chairman of the Department of Ophthalmology at Northwestern's Feinberg School of Medicine. Formerly Dr. Volpe was Professor of Ophthalmology and Neurology at the Scheie Eye Institute, University of Pennsylvania. He is recognized as a national and international leader in the field of resident graduate medical education. He had served as Director of the Ophthalmology Residency Program at Scheie from 1994 to 2010 and was Vice Chair for Clinical Affairs for the Department developing his interests and strengths as an administrative leader. He has published more than 100 scientific publications (optic nerve disease, adult strabismus surgery, pupillometry) and numerous book chapters and recently published the second edition of his textbook, Neuro-ophthalmology- -Diagnosis and Management, which is the definitive single volume text in the field of neuro-ophthalmology. He has played a prominent role nationally in improving the standards of resident education and in neuro-ophthalmology. His contributions and achievements have been recognized by awards throughout his career for both his clinical work and resident education, including winning the Senior Achievement Award from the American Academy of Ophthalmology, the Straatsma Award for excellence in resident education from the AAO and the Association of University Professors of Ophthalmology and the Robert Dunning Dripps Memorial award for excellence in graduate medical education from the University of Pennsylvania. His clinical interests are in neuro-ophthalmic disorders particularly optic nerve disease and adult strabismus surgery and research interests are in new diagnostic technologies, surgical education of ophthalmology residents and clinical trials for optic nerve disease.

Back to Board